A Study of Tadalafil for Duchenne Muscular Dystrophy

NCT01865084 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

331

Enrollment

INDUSTRY

Sponsor class

Stopped The study is being terminated for lack of efficacy

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: Tadalafil
DRUG: Placebo

Sponsor

Eli Lilly and Company